<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/30A429E3-83B7-4E41-99C0-14A144F07DFE"><gtr:id>30A429E3-83B7-4E41-99C0-14A144F07DFE</gtr:id><gtr:name>University of Southampton</gtr:name><gtr:address><gtr:line1>Administration Building</gtr:line1><gtr:line2>Highfield</gtr:line2><gtr:line4>Southampton</gtr:line4><gtr:line5>Hampshire</gtr:line5><gtr:postCode>SO17 1BJ</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/37EF6C9C-5F51-40DD-BED5-B792981BC119"><gtr:id>37EF6C9C-5F51-40DD-BED5-B792981BC119</gtr:id><gtr:name>Imperial Cancer Research Fund</gtr:name><gtr:address><gtr:line1>44 Lincoln's Inn Fields</gtr:line1><gtr:postCode>WC2A 3PX</gtr:postCode><gtr:region>London</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:department>Clinical Medicine</gtr:department><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/30A429E3-83B7-4E41-99C0-14A144F07DFE"><gtr:id>30A429E3-83B7-4E41-99C0-14A144F07DFE</gtr:id><gtr:name>University of Southampton</gtr:name><gtr:address><gtr:line1>Administration Building</gtr:line1><gtr:line2>Highfield</gtr:line2><gtr:line4>Southampton</gtr:line4><gtr:line5>Hampshire</gtr:line5><gtr:postCode>SO17 1BJ</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/37EF6C9C-5F51-40DD-BED5-B792981BC119"><gtr:id>37EF6C9C-5F51-40DD-BED5-B792981BC119</gtr:id><gtr:name>Imperial Cancer Research Fund</gtr:name><gtr:address><gtr:line1>44 Lincoln's Inn Fields</gtr:line1><gtr:postCode>WC2A 3PX</gtr:postCode><gtr:region>London</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/65AF1713-F5D3-41D8-A71A-DA5E41A4F797"><gtr:id>65AF1713-F5D3-41D8-A71A-DA5E41A4F797</gtr:id><gtr:firstName>Vincenzo</gtr:firstName><gtr:surname>Cerundolo</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G1000800"><gtr:id>C9BF0300-2C07-4CB1-867A-77E5B591AA28</gtr:id><gtr:title>University Unit Award MRC Human Immunology Unit</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G1000800</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:technicalSummary>The increasing globalisation of infectious disease is a major challenge to human health. The MRC Human Immunology Unit is a key player in international efforts to combat this threat, and in research into other diseases involving the immune system. The immune system is crucial to human health. Our ability to identify and destroy invading pathogens involves complex networks of interacting cells and molecules. Understanding precisely how the system works at the cellular, genetic and molecular levels will help in the development of new therapies for diseases such as AIDS, avian flu, multiple sclerosis, arthritis and eczema.</gtr:technicalSummary><gtr:fund><gtr:end>2012-12-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2010-04-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>8577908</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Oxford Vaccine Group</gtr:department><gtr:description>Collaboration with the Oxford Vaccine Group</gtr:description><gtr:id>DEF5606A-EE56-4F7E-B6CB-306A0BF7A598</gtr:id><gtr:impact>Collaboration still ongoing</gtr:impact><gtr:outcomeId>56deab019ea719.34225520-1</gtr:outcomeId><gtr:partnerContribution>As a joint collaboration, we are investigating disease mechanisms in enteric fever to characterise innate and adaptive immunity in mucosa and blood in controlled human infection models</gtr:partnerContribution><gtr:piContribution>In the context of the MRC Experimental Medicine Challenge Grant, my group has set up a close collaboration with the Oxford Vaccine Group directed by Professor Andrew Pollard.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Southampton</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Faculty of Medicine</gtr:department><gtr:description>Role of novel scavenger receptor in inflammatory responses of human airways</gtr:description><gtr:id>B37580E5-E721-46A0-8AC2-C69C575D1B47</gtr:id><gtr:impact>These collaborative studies are in progress but we anticipate peer-reviewed publication(s) derived from these studies within the next twelve months.</gtr:impact><gtr:outcomeId>5F0312A7D77-1</gtr:outcomeId><gtr:partnerContribution>In collaboration with Professor Donna Davies and Dr Marina Leino we are exploring the expression and biological activities of the novel scavenger receptor in the inflammatory responses of ex-vivo airway tissues from healthy and diseased donors.</gtr:partnerContribution><gtr:piContribution>We have provided expertise and knowledge as well as specific reagents to the collaboration to facilitate the studies of patient material obtained through clinical consultations</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Cancer Research UK</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Cancer Research UK London Research Institute (LRI)</gtr:department><gtr:description>B cell biology and NKT cells</gtr:description><gtr:id>DD6B4DD3-136F-45C1-BFD1-E811D95AA897</gtr:id><gtr:impact>Publications:
20228797
18550831</gtr:impact><gtr:outcomeId>miVV76zRHLH-1</gtr:outcomeId><gtr:partnerContribution>Collaborative work on the interaction of the innate and adaptive immune responses has led to two publications. The collaborator studies the role of B cells in this interaction.</gtr:partnerContribution><gtr:piContribution>Collaborative work on the interaction of the innate and adaptive immune responses has led to two publications. We study the role of NKT cells in this interaction.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Pharmacology</gtr:department><gtr:description>Role of lysosome in activation of specific pattern recognition receptors</gtr:description><gtr:id>6DEAED44-211A-4F84-B5FE-A26981149AEF</gtr:id><gtr:impact>This collaboration has resulted in the obtaining of a grant from a US based charity to financially support one aspect of the study and the results obtained to date are the basis of a recently-submitted grant application to MRC. An undergraduate project student is currently contributing to this research and a manuscript is in preparation.</gtr:impact><gtr:outcomeId>L18DUW2vGoF-1</gtr:outcomeId><gtr:partnerContribution>Provision of expertise, animal models, co-writing of grant application that led to additional grant funding, co-applicant on successful application to industrial collaborator for provision of llcensed biologic drug which will be tested in the animal models.</gtr:partnerContribution><gtr:piContribution>Made a novel observation of aberrant activation of a pro-inflammatory innate immune mechanism in a mouse model of a glycosphingolipid storage disease.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>A level student visits 2012</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>386A8671-A089-40B2-9C96-46217EB9B4AA</gtr:id><gtr:impact>2 students were hosted by members of my group for a &amp;quot;work experience week'

school would like to repeat the program in 2013</gtr:impact><gtr:outcomeId>KJWK3GV3oJx</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Magadalen College School</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>9AD8613D-3225-442B-B525-96DEE5C7AAED</gtr:id><gtr:impact>Prof. Cerundolo gave a lecture at Magadalen College School, Oxford to 130 17-year olds on the career path of scientists in which he described training and job opportunities in biomedical research

School interested in future visits</gtr:impact><gtr:outcomeId>PN3dP8aVT7M</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>Pre-2006</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Oxford Alumni</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>1F137078-7443-446A-AEBE-22353E6708F2</gtr:id><gtr:impact>Prof. Cerundolo gave a lecture on tumour immunology and cancer vaccines to a group of 130 Oxford Alumni (average age 60 years)

Talk was well received</gtr:impact><gtr:outcomeId>oAzHzYGfm4T</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>MRC Annual Review 2008-09</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>6E605493-762E-48B8-A228-788CAAB4AECE</gtr:id><gtr:impact>General description of the my research programme to a general audience

general interests towards the research programmes that we are developing in my laboratory and within the MRC Human Immunology Unit.</gtr:impact><gtr:outcomeId>43B1EC5B80D</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Oxford University Department for Continuing Education Human and Veterinary Vaccinology Course</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>B76393A2-1FD0-4DCA-99AD-C04D0BBA30F5</gtr:id><gtr:impact>During the last 2 years, the Oxford University Department for Continuing Education http://www.conted.ox.ac.uk/courses/C900-1 
has launched a leading educational programme in Vaccinology, tailored to the needs of industry in the UK and beyond, by sharing the expertise of several investigators, both at the Institute for Animal Health and across the University of Oxford, complemented by the views and experience of distinguished outside speakers. The courses run in 2010 were fully subscribed and received very good feedback from the participants. The satisfaction scores were very high: 88% for the Human and Veterinary Vaccinology; 77% for the Clinical Vaccine Development course; and 81% for the Vaccine Biomanufacturing course.
In November 2011 Prof. Cerundolo gave a talk entitled 'An Introduction to Tumour Immunology'

Course was well attended</gtr:impact><gtr:outcomeId>AdujC2g5L82</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>School Work Experience</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>0E78B4CA-5756-4806-B0F5-901F754FCF6D</gtr:id><gtr:impact>Where possible within the constraints of Health &amp;amp; Safety, the Unit welcomes sixth form students to carry out their work experience within the Unit - undertaking simple practical techniques and shadowing Unit members to get a better appreciation of a career in medical research. One student spent 1 week working in my Lab.

School asked for future opportunities</gtr:impact><gtr:outcomeId>GvNSLyxyXwc</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>140000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Cancer Research Institute USA (A phase I study of NY-ESO-1 ISCOM followed by recombinant fowlpox NY-ESO1 (rF-NY-ESO) in patients with NY-ESO-1 positive tumours)</gtr:description><gtr:end>2011-01-02</gtr:end><gtr:fundingOrg>Cancer Research Institute (CRI)</gtr:fundingOrg><gtr:id>47B0D0CF-0CDA-4B12-BCB3-443955132F38</gtr:id><gtr:outcomeId>0B40BFAD0EB0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>80000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Studentship</gtr:description><gtr:end>2014-09-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>A238AB7C-17BF-4EA2-968F-063F82BF80A5</gtr:id><gtr:outcomeId>544621b6a68b96.91985019</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>55000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Cancer Research Institute USA (Affinity maturated NY-ESO-1 157-165/HLA-A2 specific antibodies for targeting and detection of NY-ESO-1 expressing tumours)</gtr:description><gtr:end>2012-05-02</gtr:end><gtr:fundingOrg>Cancer Research Institute (CRI)</gtr:fundingOrg><gtr:id>DD837492-C0C9-443A-A364-90645DFBFBA1</gtr:id><gtr:outcomeId>812B8E5FFBF0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>150000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>CRUK Oxford Cancer Imaging Centre</gtr:description><gtr:end>2013-07-02</gtr:end><gtr:fundingOrg>Cancer Research UK</gtr:fundingOrg><gtr:id>7A12B75B-9AFA-4C47-8D5B-9F1646C5CD44</gtr:id><gtr:outcomeId>0E7F04A081F0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>214358</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Department of Health Experimental Cancer Medicine Centre: Tumour Immunology Translational Programme</gtr:description><gtr:end>2012-06-02</gtr:end><gtr:fundingOrg>Experimental Cancer Medicine Centre Network (ECMC)</gtr:fundingOrg><gtr:id>C7ECD396-343D-4DA5-BE25-1D46220454FA</gtr:id><gtr:outcomeId>5450f264d524e6.07888103</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2007-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>150000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>CRUK Oxford Cancer Imaging Centre Studentship</gtr:description><gtr:end>2013-09-02</gtr:end><gtr:fundingOrg>Cancer Research UK</gtr:fundingOrg><gtr:id>A870835A-4414-4F63-97AE-7EA3D9CE0EED</gtr:id><gtr:outcomeId>54462223954495.23204451</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1200000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>CRUK funding (Analysis of tumour-specific responses in cancer patients)</gtr:description><gtr:end>2014-09-02</gtr:end><gtr:fundingOrg>Cancer Research UK</gtr:fundingOrg><gtr:id>5E02EFEF-3E15-41CB-B7F1-AE6EC1D7B675</gtr:id><gtr:outcomeId>EA2F7763C5F0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>490000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>LICR Collaborative Research</gtr:description><gtr:end>2012-09-02</gtr:end><gtr:fundingOrg>Ludwig Institute for Cancer Research</gtr:fundingOrg><gtr:id>EDB54249-A0AD-42CA-B9D6-3D6B8F77820B</gtr:id><gtr:outcomeId>BF4874C6F2A0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>102000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Seventh Framework Programme (FP7)</gtr:department><gtr:description>Euradrenal</gtr:description><gtr:end>2012-06-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>37431ADC-0B5F-4DFA-B657-FCA339A478E2</gtr:id><gtr:outcomeId>gF89BRqfemd</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2008-04-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>A47D6CBF-883B-40EE-8A0C-CA2EC821FE37</gtr:id><gtr:title>BCR repertoire sequencing: different patterns of B-cell activation after two Meningococcal vaccines.</gtr:title><gtr:parentPublicationTitle>Immunology and cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cabb825b44455b1fd383f5bf28937ac0"><gtr:id>cabb825b44455b1fd383f5bf28937ac0</gtr:id><gtr:otherNames>Galson JD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0818-9641</gtr:issn><gtr:outcomeId>56a0a0c803ec19.14308237</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>23CB60B5-64B2-40A1-8F30-E0683CB702CB</gtr:id><gtr:title>The regulatory role of invariant NKT cells in tumor immunity.</gtr:title><gtr:parentPublicationTitle>Cancer immunology research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1d55e13bb2bca478bf77fd2f78fff1d1"><gtr:id>1d55e13bb2bca478bf77fd2f78fff1d1</gtr:id><gtr:otherNames>McEwen-Smith RM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2326-6066</gtr:issn><gtr:outcomeId>56a0a0c8aafcf0.65872713</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>79B9481F-8BCE-4C89-A02C-D05C155590D2</gtr:id><gtr:title>Analysis of B Cell Repertoire Dynamics Following Hepatitis B Vaccination in Humans, and Enrichment of Vaccine-specific Antibody Sequences.</gtr:title><gtr:parentPublicationTitle>EBioMedicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cabb825b44455b1fd383f5bf28937ac0"><gtr:id>cabb825b44455b1fd383f5bf28937ac0</gtr:id><gtr:otherNames>Galson JD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2352-3964</gtr:issn><gtr:outcomeId>58aabcba8b3507.15453748</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>75EF16F9-3DC2-4A45-8592-F82332F2A5C6</gtr:id><gtr:title>MR1-Restricted Mucosal-Associated Invariant T Cells and Their Activation during Infectious Diseases.</gtr:title><gtr:parentPublicationTitle>Frontiers in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/67f08f07df060c5266f71cbf63bc9e76"><gtr:id>67f08f07df060c5266f71cbf63bc9e76</gtr:id><gtr:otherNames>Howson LJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1664-3224</gtr:issn><gtr:outcomeId>56a0a0c7cd6265.00428846</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5C2ED8EA-B3E6-42BD-8081-5DDDED06B23A</gtr:id><gtr:title>Bee venom processes human skin lipids for presentation by CD1a.</gtr:title><gtr:parentPublicationTitle>The Journal of experimental medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b35c1f191240d89a521fb16991424bd0"><gtr:id>b35c1f191240d89a521fb16991424bd0</gtr:id><gtr:otherNames>Bourgeois EA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0022-1007</gtr:issn><gtr:outcomeId>56a0a0c93e1ed9.00336240</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>87CA5AE0-094F-4EE4-9072-5BD5EA01D956</gtr:id><gtr:title>The location of splenic NKT cells favours their rapid activation by blood-borne antigen.</gtr:title><gtr:parentPublicationTitle>The EMBO journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ed032268c749fe13105b28653a67c1d5"><gtr:id>ed032268c749fe13105b28653a67c1d5</gtr:id><gtr:otherNames>Barral P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0261-4189</gtr:issn><gtr:outcomeId>pm_14351_21_22505026</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B5FCD2F5-54F0-4F46-824B-C630E3DC9E53</gtr:id><gtr:title>Failure to detect production of IL-10 by activated human neutrophils.</gtr:title><gtr:parentPublicationTitle>Nature immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/962837fe8eeebd72e53c9816bd4f9676"><gtr:id>962837fe8eeebd72e53c9816bd4f9676</gtr:id><gtr:otherNames>Davey MS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1529-2908</gtr:issn><gtr:outcomeId>oavfZ6NnXAN</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A61CB43C-AF97-4EB1-86F2-CA2B9653CF29</gtr:id><gtr:title>Identification of Bcl-6-dependent follicular helper NKT cells that provide cognate help for B cell responses.</gtr:title><gtr:parentPublicationTitle>Nature immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6dd7df21beeebdf22230b26307bee08e"><gtr:id>6dd7df21beeebdf22230b26307bee08e</gtr:id><gtr:otherNames>Chang PP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1529-2908</gtr:issn><gtr:outcomeId>pm_14351_21_22120117</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>38A4D99A-DDC6-488D-8753-B94E22EBB288</gtr:id><gtr:title>The Processed Amino-Terminal Fragment of Human TLR7 Acts as a Chaperone To Direct Human TLR7 into Endosomes.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2dd798d753b6242950f4fe4166551ba7"><gtr:id>2dd798d753b6242950f4fe4166551ba7</gtr:id><gtr:otherNames>Hipp MM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>5675e34faafb7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2990B5E3-9077-4C47-AA6F-0B67832ABB3F</gtr:id><gtr:title>Expansion of highly activated invariant natural killer T cells with altered phenotype in acute dengue infection.</gtr:title><gtr:parentPublicationTitle>Clinical and experimental immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5253ccac976e8e8fdf9eba0567d80417"><gtr:id>5253ccac976e8e8fdf9eba0567d80417</gtr:id><gtr:otherNames>Kamaladasa A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0009-9104</gtr:issn><gtr:outcomeId>56d964067cb079.74553004</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>858DD6E0-42E1-4464-84A9-4500AB811E2A</gtr:id><gtr:title>Saposins modulate human invariant Natural Killer T cells self-reactivity and facilitate lipid exchange with CD1d molecules during antigen presentation.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cdd7cfa24aca2bdff2a40d8bc27c2f1e"><gtr:id>cdd7cfa24aca2bdff2a40d8bc27c2f1e</gtr:id><gtr:otherNames>Salio M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>pm_14351_21_24248359</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>84A10E4C-8C35-4126-A7D3-675FA1BA8444</gtr:id><gtr:title>Globosides but not isoglobosides can impact the development of invariant NKT cells and their interaction with dendritic cells.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f71c646940318407a3861110bf2de944"><gtr:id>f71c646940318407a3861110bf2de944</gtr:id><gtr:otherNames>Porubsky S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>pm_14351_21_22875802</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E9A4A324-DB33-4331-8DD7-A87F0325F849</gtr:id><gtr:title>NY-ESO-1 protein glycosylated by yeast induces enhanced immune responses.</gtr:title><gtr:parentPublicationTitle>Yeast (Chichester, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9d1ca22809264f6b5d96e05bb41b4190"><gtr:id>9d1ca22809264f6b5d96e05bb41b4190</gtr:id><gtr:otherNames>Wadle A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0749-503X</gtr:issn><gtr:outcomeId>VNxRkvRKYM1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B81E2B63-65F4-4F36-BB18-93D854E1C755</gtr:id><gtr:title>NAADP activates two-pore channels on T cell cytolytic granules to stimulate exocytosis and killing.</gtr:title><gtr:parentPublicationTitle>Current biology : CB</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2b1d9c86788c1281ca4ae8c3808452fe"><gtr:id>2b1d9c86788c1281ca4ae8c3808452fe</gtr:id><gtr:otherNames>Davis LC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0960-9822</gtr:issn><gtr:outcomeId>pm_14351_21_23177477</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>713B9DA1-83AE-4AC3-A45C-DBF04523C867</gtr:id><gtr:title>Active nuclear transcriptome analysis reveals inflammasome-dependent mechanism for early neutrophil response to Mycobacterium marinum.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b56478981f0cc0b398ee81ce24b83b3d"><gtr:id>b56478981f0cc0b398ee81ce24b83b3d</gtr:id><gtr:otherNames>Kenyon A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>599ec87b779f15.99934104</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4C6C76A8-7C1D-4A42-A301-34DF121040E0</gtr:id><gtr:title>Cross-presentation of tumour antigens by human induced pluripotent stem cell-derived CD141(+)XCR1+ dendritic cells.</gtr:title><gtr:parentPublicationTitle>Gene therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/334bb3fa06ba7049928f293fe6c4d46a"><gtr:id>334bb3fa06ba7049928f293fe6c4d46a</gtr:id><gtr:otherNames>Silk KM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0969-7128</gtr:issn><gtr:outcomeId>pm_53cd4b6d4b60d13e5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8DFA4302-1AB8-487B-A123-59787E1C3110</gtr:id><gtr:title>IDO induces expression of a novel tryptophan transporter in mouse and human tumor cells.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/49a45bc2b3cb7e3f4064a9dce2caec9a"><gtr:id>49a45bc2b3cb7e3f4064a9dce2caec9a</gtr:id><gtr:otherNames>Silk JD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>G5dAUdSAQyU</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>90BC234E-2B14-4C67-8037-8F0A28E546E3</gtr:id><gtr:title>Dendritic cells enter lymph vessels by hyaluronan-mediated docking to the endothelial receptor LYVE-1.</gtr:title><gtr:parentPublicationTitle>Nature immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4045ec99722c5d534bac690f76cfe482"><gtr:id>4045ec99722c5d534bac690f76cfe482</gtr:id><gtr:otherNames>Johnson LA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1529-2908</gtr:issn><gtr:outcomeId>599ec9119f4109.84618966</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>88A7C767-291A-42A2-BF20-747D9172C964</gtr:id><gtr:title>Modulation of cancer-specific immune responses by amino acid degrading enzymes.</gtr:title><gtr:parentPublicationTitle>Immunotherapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/308df9ed4646591061d92bfb2f8f47f6"><gtr:id>308df9ed4646591061d92bfb2f8f47f6</gtr:id><gtr:otherNames>Timosenko E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1750-743X</gtr:issn><gtr:outcomeId>58aabcb9b85e29.51068240</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>91EBED6A-AAD3-4312-93D3-D2A657357A11</gtr:id><gtr:title>Kinetics and mechanics of two-dimensional interactions between T cell receptors and different activating ligands.</gtr:title><gtr:parentPublicationTitle>Biophysical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0a0e94d1951bdc0c24b6d4977fd54a5a"><gtr:id>0a0e94d1951bdc0c24b6d4977fd54a5a</gtr:id><gtr:otherNames>Robert P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0006-3495</gtr:issn><gtr:outcomeId>pm_14351_21_22339861</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>63319B52-2A3C-403D-91F4-147B255C4B73</gtr:id><gtr:title>Chasing flies because time flies.</gtr:title><gtr:parentPublicationTitle>Journal of innate immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/297e60d00493b61bbc3912f6acef33d8"><gtr:id>297e60d00493b61bbc3912f6acef33d8</gtr:id><gtr:otherNames>Herwald H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1662-811X</gtr:issn><gtr:outcomeId>56a0a0c82d69d2.53711809</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BAEC2173-49A5-4313-901A-A8AE03C4637D</gtr:id><gtr:title>Non-glycosidic compounds can stimulate both human and mouse iNKT cells.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0b82391780be83628fc99fe5451faae5"><gtr:id>0b82391780be83628fc99fe5451faae5</gtr:id><gtr:otherNames>Jukes JP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn><gtr:outcomeId>56d96406a12103.66133187</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8850E724-F30E-4EB3-B5CB-D985684D2F7A</gtr:id><gtr:title>Activation of Human Mucosal-Associated Invariant T Cells Induces CD40L-Dependent Maturation of Monocyte-Derived and Primary Dendritic Cells.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cdd7cfa24aca2bdff2a40d8bc27c2f1e"><gtr:id>cdd7cfa24aca2bdff2a40d8bc27c2f1e</gtr:id><gtr:otherNames>Salio M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>5a31d5925e4d26.48392838</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5919E8DE-5A50-4F62-A790-3C186EB9B1C2</gtr:id><gtr:title>Co-delivery of PLGA encapsulated invariant NKT cell agonist with antigenic protein induce strong T cell-mediated antitumor immune responses.</gtr:title><gtr:parentPublicationTitle>Oncoimmunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9b045ced11ecc86a5f60212689717498"><gtr:id>9b045ced11ecc86a5f60212689717498</gtr:id><gtr:otherNames>D?len Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2162-4011</gtr:issn><gtr:outcomeId>58aabcbabd1f97.31749247</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9D8342AD-D1E2-4D06-B82F-00651DE5B6DD</gtr:id><gtr:title>Towards multivalent CD1d ligands: synthesis and biological activity of homodimeric a-galactosyl ceramide analogues.</gtr:title><gtr:parentPublicationTitle>Carbohydrate research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3bc556e8a52dfe9b143535b3a1ef5857"><gtr:id>3bc556e8a52dfe9b143535b3a1ef5857</gtr:id><gtr:otherNames>Jervis PJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0008-6215</gtr:issn><gtr:outcomeId>pm_14351_21_22445102</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>57BCCA96-358F-4680-A142-76A9D2C6092E</gtr:id><gtr:title>The actin cytoskeleton modulates the activation of iNKT cells by segregating CD1d nanoclusters on antigen-presenting cells.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6de2737c81a157a81c65fd17e9d448b5"><gtr:id>6de2737c81a157a81c65fd17e9d448b5</gtr:id><gtr:otherNames>Torreno-Pina JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>56d9646728e6b6.40279545</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>36541765-CADC-46AB-B6E5-143626BED89C</gtr:id><gtr:title>Centriole polarisation to the immunological synapse directs secretion from cytolytic cells of both the innate and adaptive immune systems.</gtr:title><gtr:parentPublicationTitle>BMC biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/745674873575c58989eaec9fa740d98d"><gtr:id>745674873575c58989eaec9fa740d98d</gtr:id><gtr:otherNames>Stinchcombe JC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1741-7007</gtr:issn><gtr:outcomeId>mAshZnsDnMH</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>85D800A1-7605-4EC0-B6DC-535125E16F1E</gtr:id><gtr:title>Antigen potency and maximal efficacy reveal a mechanism of efficient T cell activation.</gtr:title><gtr:parentPublicationTitle>Science signaling</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f2f2bd7f336da8c018723aeaf0de7f58"><gtr:id>f2f2bd7f336da8c018723aeaf0de7f58</gtr:id><gtr:otherNames>Dushek O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1945-0877</gtr:issn><gtr:outcomeId>P3Rs4TURzMU</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E8E26397-8B1E-4711-9A4E-7E9BB6C0A9AB</gtr:id><gtr:title>Regulation of Lipid Specific and Vitamin Specific Non-MHC Restricted T Cells by Antigen Presenting Cells and Their Therapeutic Potentials.</gtr:title><gtr:parentPublicationTitle>Frontiers in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cdd7cfa24aca2bdff2a40d8bc27c2f1e"><gtr:id>cdd7cfa24aca2bdff2a40d8bc27c2f1e</gtr:id><gtr:otherNames>Salio M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1664-3224</gtr:issn><gtr:outcomeId>56a0a0c96309f1.81287941</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>180A0FBB-85A3-4A24-A371-210DBE5F12D4</gtr:id><gtr:title>Recent advances in processing and presentation of CD1 bound lipid antigens.</gtr:title><gtr:parentPublicationTitle>Current opinion in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cdd7cfa24aca2bdff2a40d8bc27c2f1e"><gtr:id>cdd7cfa24aca2bdff2a40d8bc27c2f1e</gtr:id><gtr:otherNames>Salio M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0952-7915</gtr:issn><gtr:outcomeId>pm_14351_21_20080041</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1C9D6920-23DE-4232-8974-09712BDD1678</gtr:id><gtr:title>Characterization of human DNGR-1+ BDCA3+ leukocytes as putative equivalents of mouse CD8alpha+ dendritic cells.</gtr:title><gtr:parentPublicationTitle>The Journal of experimental medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6bb9933d7677bfa255cf9e7b6cc37e5b"><gtr:id>6bb9933d7677bfa255cf9e7b6cc37e5b</gtr:id><gtr:otherNames>Poulin LF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-1007</gtr:issn><gtr:outcomeId>58aabcbcd53e60.33918480</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BA9C9096-2873-425A-9674-061546685B43</gtr:id><gtr:title>B-cell repertoire dynamics after sequential hepatitis B vaccination and evidence for cross-reactive B-cell activation.</gtr:title><gtr:parentPublicationTitle>Genome medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cabb825b44455b1fd383f5bf28937ac0"><gtr:id>cabb825b44455b1fd383f5bf28937ac0</gtr:id><gtr:otherNames>Galson JD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1756-994X</gtr:issn><gtr:outcomeId>58aabcba5b08b7.14297213</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>91A4037C-BAA7-4BCB-896B-793B6E8A9644</gtr:id><gtr:title>Amide analogues of CD1d agonists modulate iNKT-cell-mediated cytokine production.</gtr:title><gtr:parentPublicationTitle>ACS chemical biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6fb13f7f6726d418d15c6c07708d5457"><gtr:id>6fb13f7f6726d418d15c6c07708d5457</gtr:id><gtr:otherNames>Wojno J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1554-8929</gtr:issn><gtr:outcomeId>pm_14351_21_22324848</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BDF58CC3-FD58-43BD-80D3-D07059216702</gtr:id><gtr:title>Nutritional Stress Induced by Tryptophan-Degrading Enzymes Results in ATF4-Dependent Reprogramming of the Amino Acid Transporter Profile in Tumor Cells.</gtr:title><gtr:parentPublicationTitle>Cancer research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/308df9ed4646591061d92bfb2f8f47f6"><gtr:id>308df9ed4646591061d92bfb2f8f47f6</gtr:id><gtr:otherNames>Timosenko E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0008-5472</gtr:issn><gtr:outcomeId>58aabcb9e0b7b4.38106458</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1647915B-F793-47B5-AA9E-E3761BD1DD77</gtr:id><gtr:title>Binding strength and dynamics of invariant natural killer cell T cell receptor/CD1d-glycosphingolipid interaction on living cells by single molecule force spectroscopy.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1e7a96225e57f23e027a96f9169f26cc"><gtr:id>1e7a96225e57f23e027a96f9169f26cc</gtr:id><gtr:otherNames>Bozna BL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>ToX9MtVVhvz</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>148D38FA-FBF1-468D-B4AF-C0B973871B7D</gtr:id><gtr:title>T lymphocytes need less than 3 min to discriminate between peptide MHCs with similar TCR-binding parameters.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/74df5c84b51c02bff3ba1fbba395c41a"><gtr:id>74df5c84b51c02bff3ba1fbba395c41a</gtr:id><gtr:otherNames>Brodovitch A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn><gtr:outcomeId>56a0a0c998c334.88974248</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>353F5109-0A1F-4514-B02F-58DE4C8E338A</gtr:id><gtr:title>Invariant NKT cells modulate the suppressive activity of IL-10-secreting neutrophils differentiated with serum amyloid A.</gtr:title><gtr:parentPublicationTitle>Nature immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d09a00d7c724d63247a15b7e5419d9c5"><gtr:id>d09a00d7c724d63247a15b7e5419d9c5</gtr:id><gtr:otherNames>De Santo C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1529-2908</gtr:issn><gtr:outcomeId>58aabcbc7e7e90.45394937</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>772F9885-9CDB-4F0E-B46B-715FFF434F73</gtr:id><gtr:title>Human autoreactive T cells recognize CD1b and phospholipids.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d47083a7f870923cea9bf716967da545"><gtr:id>d47083a7f870923cea9bf716967da545</gtr:id><gtr:otherNames>Van Rhijn I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>56a0a4dceea429.03714048</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E4B62CAE-D7E9-4DEF-8B21-002FA1BFCAD4</gtr:id><gtr:title>In-Depth Assessment of Within-Individual and Inter-Individual Variation in the B Cell Receptor Repertoire.</gtr:title><gtr:parentPublicationTitle>Frontiers in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cabb825b44455b1fd383f5bf28937ac0"><gtr:id>cabb825b44455b1fd383f5bf28937ac0</gtr:id><gtr:otherNames>Galson JD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1664-3224</gtr:issn><gtr:outcomeId>56a0a0c87a1938.62095893</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>94589087-98E8-42C6-9A5C-5E390588466B</gtr:id><gtr:title>Constitutively active Lck kinase in T cells drives antigen receptor signal transduction.</gtr:title><gtr:parentPublicationTitle>Immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ff1acd48b435d6ed60d479e0726c769f"><gtr:id>ff1acd48b435d6ed60d479e0726c769f</gtr:id><gtr:otherNames>Nika K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1074-7613</gtr:issn><gtr:outcomeId>58aabcbca9a4e8.26641004</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>499793B5-F102-4F59-B82A-9B2B0180B833</gtr:id><gtr:title>Preparation, characterisation and entrapment of a non-glycosidic threitol ceramide into liposomes for presentation to invariant natural killer T cells.</gtr:title><gtr:parentPublicationTitle>Journal of pharmaceutical sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/26134f681f6cf55c84202737dc3ce3e7"><gtr:id>26134f681f6cf55c84202737dc3ce3e7</gtr:id><gtr:otherNames>Kaur R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-3549</gtr:issn><gtr:outcomeId>dJWqfBrzT2c</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>16B1B115-4588-4121-A71C-F6EF39112CCC</gtr:id><gtr:title>Interaction between invariant NKT cells and myeloid-derived suppressor cells in cancer patients: evidence and therapeutic opportunities.</gtr:title><gtr:parentPublicationTitle>Journal of immunotherapy (Hagerstown, Md. : 1997)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9fe1d78d9f73909aa0285fb1be6f87e2"><gtr:id>9fe1d78d9f73909aa0285fb1be6f87e2</gtr:id><gtr:otherNames>Mussai F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1524-9557</gtr:issn><gtr:outcomeId>pm_14351_21_22735803</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D306078F-7A80-49FF-9CC4-046A32DDB401</gtr:id><gtr:title>Synthesis of truncated analogues of the iNKT cell agonist, a-galactosyl ceramide (KRN7000), and their biological evaluation.</gtr:title><gtr:parentPublicationTitle>Bioorganic &amp; medicinal chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b71cc096b28f5d38b81344d4bdd2b9bd"><gtr:id>b71cc096b28f5d38b81344d4bdd2b9bd</gtr:id><gtr:otherNames>Veerapen N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0968-0896</gtr:issn><gtr:outcomeId>eY5JjyC2rbi</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B305C5A6-7E15-4516-B07E-F90A2BD2EDF9</gtr:id><gtr:title>CD1d-dependent endogenous and exogenous lipid antigen presentation.</gtr:title><gtr:parentPublicationTitle>Current opinion in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1d55e13bb2bca478bf77fd2f78fff1d1"><gtr:id>1d55e13bb2bca478bf77fd2f78fff1d1</gtr:id><gtr:otherNames>McEwen-Smith RM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0952-7915</gtr:issn><gtr:outcomeId>56a0a0c856aea5.23452831</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ED47C132-8890-4984-AB1F-58F57D044C63</gtr:id><gtr:title>A dominant role for the immunoproteasome in CD8+ T cell responses to murine cytomegalovirus.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d54e30e2c879943d1c7bb02b8ac6559b"><gtr:id>d54e30e2c879943d1c7bb02b8ac6559b</gtr:id><gtr:otherNames>Hutchinson S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>hwZBmyjXL7M</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3670F29D-68B5-44F8-BA25-B1E069E1F700</gtr:id><gtr:title>Prostaglandin E2 suppresses the differentiation of retinoic acid-producing dendritic cells in mice and humans.</gtr:title><gtr:parentPublicationTitle>The Journal of experimental medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ac7e26fc7687dfd51f87121e4632ed91"><gtr:id>ac7e26fc7687dfd51f87121e4632ed91</gtr:id><gtr:otherNames>Stock A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-1007</gtr:issn><gtr:outcomeId>Dmzuiear9Lq</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8D93D73B-531E-47F8-9546-8EB05D490AC9</gtr:id><gtr:title>Diverse endogenous antigens for mouse NKT cells: self-antigens that are not glycosphingolipids.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a65f8968616393ae77c7eee04bbea2fd"><gtr:id>a65f8968616393ae77c7eee04bbea2fd</gtr:id><gtr:otherNames>Pei B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>j1fqFMWfMFx</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>06CFBE93-9A45-4A0D-8D0E-C5CF9C9B68A4</gtr:id><gtr:title>Systems biology of immunity to MF59-adjuvanted versus nonadjuvanted trivalent seasonal influenza vaccines in early childhood.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/07fefc16726e8220ca1003792597d1ee"><gtr:id>07fefc16726e8220ca1003792597d1ee</gtr:id><gtr:otherNames>Nakaya HI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>56a0a5c65a5835.45643304</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E7F34BFE-6EBC-4091-B539-4D83594DD198</gtr:id><gtr:title>Erratum to: B-cell repertoire dynamics after sequential hepatitis B vaccination and evidence for cross-reactive B-cell activation.</gtr:title><gtr:parentPublicationTitle>Genome medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cabb825b44455b1fd383f5bf28937ac0"><gtr:id>cabb825b44455b1fd383f5bf28937ac0</gtr:id><gtr:otherNames>Galson JD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1756-994X</gtr:issn><gtr:outcomeId>58aabcba3a2822.64658796</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G1000800</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>C6D70A71-8796-47BC-AFE0-CC2286E66A06</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Inflammatory and Immune System</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>